On 1 October 2014, AmbulanzPartner and Ipsen Pharma are launching a research project to investigate the opportunities offered by digitalization and networking in complex outpatient spasticity treatment.
Through AmbulanzPartner.de, all those involved in spasticity treatment are networked in terms of information technology and services. The Internet portal connects specialists, pharmacists, providers of remedies and aids as well as patients and other roles authorized by the patient.
The use of AmbulanzPartner.de serves the purpose of care and quality management in spasticity treatment with botulinum toxin as well as the associated care and service research.
The worldwide unique scientific project is planned for a period of two years and will involve around 100 people with spasticity as a result of a stroke.